Drexel Morgan & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.66M | Hold |
2,134
| – | – | 0.3% | 33 |
|
2025
Q1 | $1.76M | Hold |
2,134
| – | – | 0.37% | 32 |
|
2024
Q4 | $1.65M | Hold |
2,134
| – | – | 0.34% | 34 |
|
2024
Q3 | $1.89M | Hold |
2,134
| – | – | 0.35% | 33 |
|
2024
Q2 | $1.93M | Hold |
2,134
| – | – | 0.41% | 29 |
|
2024
Q1 | $1.66M | Hold |
2,134
| – | – | 0.34% | 32 |
|
2023
Q4 | $1.24M | Buy |
2,134
+134
| +7% | +$78.1K | 0.29% | 33 |
|
2023
Q3 | $1.07M | Hold |
2,000
| – | – | 0.29% | 34 |
|
2023
Q2 | $938K | Hold |
2,000
| – | – | 0.24% | 37 |
|
2023
Q1 | $687K | Hold |
2,000
| – | – | 0.17% | 37 |
|
2022
Q4 | $732K | Hold |
2,000
| – | – | 0.15% | 37 |
|
2022
Q3 | $647K | Hold |
2,000
| – | – | 0.16% | 37 |
|
2022
Q2 | $648K | Hold |
2,000
| – | – | 0.18% | 36 |
|
2022
Q1 | $573K | Hold |
2,000
| – | – | 0.17% | 35 |
|
2021
Q4 | $552K | Hold |
2,000
| – | – | 0.16% | 37 |
|
2021
Q3 | $462K | Sell |
2,000
-500
| -20% | -$116K | 0.15% | 36 |
|
2021
Q2 | $574K | Buy |
2,500
+500
| +25% | +$115K | 0.17% | 51 |
|
2021
Q1 | $374K | Sell |
2,000
-6
| -0.3% | -$1.12K | 0.09% | 76 |
|
2020
Q4 | $339K | Hold |
2,006
| – | – | 0.09% | 76 |
|
2020
Q3 | $297K | Hold |
2,006
| – | – | 0.1% | 79 |
|
2020
Q2 | $329K | Hold |
2,006
| – | – | 0.12% | 77 |
|
2020
Q1 | $278K | Hold |
2,006
| – | – | 0.11% | 75 |
|
2019
Q4 | $264K | Buy |
2,006
+6
| +0.3% | +$790 | 0.2% | 76 |
|
2019
Q3 | $224K | Hold |
2,000
| – | – | 0.17% | 81 |
|
2019
Q2 | $222K | Hold |
2,000
| – | – | 0.17% | 85 |
|
2019
Q1 | $260K | Hold |
2,000
| – | – | 0.23% | 78 |
|
2018
Q4 | $231K | Hold |
2,000
| – | – | 0.23% | 82 |
|
2018
Q3 | $215K | Buy |
+2,000
| New | +$215K | 0.19% | 88 |
|
2018
Q1 | – | Sell |
-2,645
| Closed | -$223K | – | 88 |
|
2017
Q4 | $223K | Hold |
2,645
| – | – | 0.22% | 86 |
|
2017
Q3 | $226K | Hold |
2,645
| – | – | 0.23% | 84 |
|
2017
Q2 | $218K | Buy |
+2,645
| New | +$218K | 0.22% | 82 |
|